FASLG and central nervous system cancer: FAS and FAS-L reduced expression was also observed in glioma stem cells (GSCs) and the use of a synthetic FAS-L, Apo010, in combination with temozolomide induced apoptosis in glioblastoma (GBM) stem-like cells (38, 39).